Episode Synopsis "Biopharma Annual Planning Success: Close Your Rings Year-Round"

Can We Think About Annual Planning in Biopharma Differently? Lessons from Exercise and Fitness Trackers.

Listen "Biopharma Annual Planning Success: Close Your Rings Year-Round"

More episodes of the podcast Connecting the Dots

• BIO and Boston: The Global Stage and HLYB
• Season of Transitions
• Musings on Women’s History Month
• Connect, Communicate, and Conquer 2025
• Changing Lanes: My Shift from Performer to Leader
• The Basics of Gratitude
• Power of Questions
• The Underappreciated Value of New Product Planning
• Biopharma Annual Planning Success: Close Your Rings Year-Round
• Unlocking Success: The Power of Target Product Profiles
• Unfinished Business on the Glass Ceiling
• Success in Rare Disease: Patient Involvement Matters!
• Happy Anniversary to Us!
• Hybrid Work Strategies: 3 Tips to Transform Engagement
• Medical Affairs: An Orchestra, Not a Race
• Three Big Mistakes
• What's The Latest?
• Gen Z Advice for Seasoned Boomers
• Find Your Own Light
• Running The Biopharma Marathon
• “Rare Disease” Is More Than Just a Day
• Moving Beyond The One-Hit Wonder
• Optimizing Collaboration between Commercial and Medical Affairs
• The Importance of a Commercialization Mindset
• Be Bold and Take Risks
• Optimize Your Congress Planning
• Communicating Without A Communication Leader
• Appreciation for Interconnectedness
• Moments That Matter
• Commercialization - A Mindset, Not a Function
• Start Too Early... Before it's Too Late
• Freedom to Lead
• Pandemic-Inspired Thought Bubbles
• Solving the Hiring Puzzle
• Notes from the Un-Empty Nest
• Rare Diseases — It's All About the Patient
• Planning Amidst the Mayhem
• My Big Announcement
• Reverse Mentoring with Up-and-Coming Talent
• Commercialization Street Smarts to Inform Your S-1 Business Section
• An Abundance of Riches in Uncertain Times
• There Is No Such Thing As A Free Launch
• Making Virtual Workshops Work
• Are You Getting the Most Out of Your Consultants?
• Where Has All The Strategy Gone?